Data as of Jan 30
| -0.10 / -1.87%|
The 6 analysts offering 12-month price forecasts for Orexigen Therapeutics Inc have a median target of 10.00, with a high estimate of 16.00 and a low estimate of 9.00. The median estimate represents a +90.48% increase from the last price of 5.25.
The current consensus among 7 polled investment analysts is to Buy stock in Orexigen Therapeutics Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.